Synthesis, antimalarial activity, and molecular modeling of tebuquine analogues

Journal of Medicinal Chemistry

Volumn 40, Issue 4, 1997, Pages 437-448

  O'Neill, Paul M ^a   Willock, David J ^a   Hawley, Shaun R ^a   Bray, Patrick G ^a   Storr, Richard C ^a   Ward, Stephen A ^a   Park, B Kevin ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMOTEBUQUINE; ANTIMALARIAL AGENT; CHLOROQUINE; DEHYDROXYTEBUQUINE; FLUOROAMOTEBUQUINE; FLUOROTEBUQUINE; TEBUQUINE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG RESISTANCE; DRUG SYNTHESIS; FLUORINATION; HYDROGENATION; MOLECULAR INTERACTION; MOLECULAR MODEL; NONHUMAN; STRAIN DIFFERENCE; STRUCTURE ACTIVITY RELATION;

AMINOQUINOLINES; AMODIAQUINE; ANIMALS; ANTIMALARIALS; HEME; HUMANS; MODELS, MOLECULAR; PLASMODIUM FALCIPARUM;

EID: 0031055744     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960370r     Document Type: Article

References (47)

1. WHO Practical Chemotherapy of Malaria; Technical Report Series No. 805; World Health Organization: Geneva, 1990.
2. Hawley, S. R.; Bray, P. G.; O'Neill, P. M.; Park, B. K.; Ward, S. A. The Role of Drug Accumulation in 4-Aminoquinoline Antimalarial Potency: The Influence of Structural Substitution and Physicochemical Properties. Biochem. Pharmacol. 1996, 52, 723-733.
3. Werbel, L. M.; Cook, P. D.; Elslager, E. F.; Hung, J. H.; Johnson, J. L.; Keston, S. J.; McNamara, D. J.; Ortwine, D. F; Worth, D. F., Synthesis, Antimalarial Activity and Quantitative Structure-Activity Relationships of Tebuquine and a Series of Related 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl][1,1′-biphenyl]-2- ols and N-oxides. J. Med. Chem. 1986, 29, 924-939.
4. Lind, D. E.; Levi, J. A.; Vincent, P. C. Amodiaquine Induced Agranulocytosis; Toxic Effects of Amodiaquine in Bone Marrow Culture In Vitro. Br. Med. J. 1973, 1, 458-460.
5. Maggs, J. L.; Kitteringham, N. R.; Park, B. K. Drug Protein Conjugates-XIV. Mechanism of Formation of Protein Arylating Intermediates From Amodiaquine a Myelotoxin and Hepatotoxin in Man. Biochem. Pharmacol. 1988, 37, 303-311.
6. Harrison, A. C.; Kitteringham, N. R.; Clarke, J. B.; Park, B. K. The Mechanism of Bioactivation and Antigen Formation of Amodiaquine in the Rat. Biochem. Pharmacol. 1992, 43, 1421-1430.
7. O'Neill, P. M.; Harrison, A. C.; Storr, R. C.; Hawley, S. R.; Ward, S. A.; Park, B. K. The Effect of Fluorine Substitution on the Metabolism and Antimalarial Activity of Amodiaquine. J. Med. Chem. 1994, 37, 1362-1370.
8. Ruscoe, J. E.; Jewell, H.; Maggs, J. L.; O'Neill, P. M.; Storr, R. C.; Ward, S. A.; Park, B. K. The Effect of Chemical Substitution on the Metabolic Activation, Metabolic Detoxication, and Pharmacological Activity of Amodiaquine in the Mouse. J. Pharmacol. Exp. Ther. 1995, 273, 393-404.
9. Jewell, H.; Maggs, J. L.; Ruscoe, J. E.; Harrison, A. C.; O'Neill, P. M.; Ruscoe, J. E.; Park, B. K. The Role of Hepatic Metabolism in the Bioactivation and Detoxication of Amodiaquine. Xenobiotica 1995, 25, 199-217.
10. Tingle, M. D.; Jewell, H.; Maggs, J. L.; O'Neill, P. M.; Park, B. K. The Bioactivation of Amodiaquine by Human Polymorphonuclear Leucocytes In Vitro: Chemical Mechanisms and the Effects of Fluorine Substitution. Biochem. Pharmacol. 1995, 50, 1113-1119.
11. O'Neill, P. M.; Tingle, M. D.; Mahmud, R.; Storr, R. C.; Ward, S. A.; Park, B. K. The Effect of Fluorine Substitution on the Haemotoxicity of Primaquine. Bio. Med. Chem. Lett. 1995, 20, 2309-2314.
12. Hawley, S. R.; Bray, P. G.; O'Neill, P. M.; Naisbitt, D. J.; Park, B. K.; Ward, S. A. Manipulation of the N-alkyl Substituent in Amodiaquine to Overcome the Verapamil Sensitive Chloroquine Resistance Component. Antimicrob. Chemother. 1996, in press.
13. Chou, A. C.; Chevli, R.; Fitch, C. D. Ferriprotoporphyrin IX Fulfills the Criteria for Identification as the Chloroquine Receptor of Malaria Parasites. Biochemistry 1980, 19, 1543-1549.
14. Blauer, G.; Akkawi, M.; Bauminger, E. R. Further Evidence for the Interaction of the Antimalarial Drug Amodiaquine with Ferriprotoporphyrin IX. Biochem. Pharmacol. 1993, 46, 1573-1576.
15. Ginsburg, H.; Krugliak, M. Quinoline Containing Antimalarials: Mode of Action, Drug-Resistance and Its Reversal. An Update with Unresolved Puzzles. Biochem. Pharmacol. 1992, 43, 63-70.
16. Geary, T. G.; Divo, A. D.; Jensen, J. B.; Zangwill, M.; Ginsburg, H. Kinetic modeling of the Response of Plasmodium falciparum to Chloroquine and its Experimental Testing In Vitro. Implications for Mechanism of Action and Resistance to the Drug. Biochem. Pharmacol. 1990, 40, 685-691.
17. Fanta, P. E. The Ullman Synthesis of Biaryls. Chem. Rev. 1946, 38, 139.
18. Hill, H. B.; Hale, W. J. Am. Chem. Soc. 1905, 33, 1.
19. Lauer, W. L.; Rondestvedt, C.; Arnold, R. T.; Drake, N. L.; Van Hook, J.; Tinker, J. Some Derivatives of 8-Aminoquinoline. J. Am. Chem. Soc. 1946, 68, 1546.
20. Miyaura, N.; Yanagi, T.; Suzuki, A. The Palladium-Catalyzed Cross-Coupling Reaction of Phenylboronic Acid with Haloarenes in the Presence of Bases. Synth. Commun. 1981, 11, 513-519.
21. Jensen, J. B.; Trager, W. Plasmodium Falciparum in Culture: Use of Outdated Erythrocytes and Description of the Candle Jar Method. J. Parasitol. 1977, 63, 883-886.
22. Desjardins, R. E.; Canfield, J.; Haynes, D.; Chulay, D. J. Quantitative Assessment of Antimalarial Activity In Vitro by a Semi-automated Microdilution Technique. Antimicrob. Agents. Chemother. 1979, 16, 710-718.
23. Koh, H. L.; Go, M. L.; Ngiam, T. L.; Mak, J. W. Conformational and Structural Features Determining In Vitro Antimalarial Activity in Some Indolo[3,2-c]quinolines, anilinoquinolines and tetrahydroindolo[3,2-d] benzazepeines. Eur. J. Med. Chem. 1994, 29, 107-113.
24. Polowin, J.; Poer Baird, M. C. Extensions of the Applicability of the MMX Molecular modeling System in the Determination of Barriers to Rotation of pi-Bonded Ligands. Can. J. Chem. 1995, 73, 1078-1083.
25. Stewart, J. J. P. Mopac - A Semiempirical Molecular-Orbital Program. J. Comput.-Aided Mol. Des. 1990, 4, 1-45.
26. Discover, 1993, Biosym Technologies Inc., San Diego, CA 92121-2777.
27. Barlow, S.; Rohl, A. L.; O'Hare, D. Molecular-Mechanics Study of Oligomeric Models for Polyferrocenylsilanes Using the Esff Forcefield. Chem. Commun. 1996, 256. For another example of molecular modeling on hemes, see: Ranghino, G.; Fantucci, P. Molecular modeling of Heme Peptides-Molecular Dynamics Simulation of Microperoxidase. Israel Chem. 1994, 34, 239-244.
28. Barlow, S.; Rohl, A. L.; O'Hare, D. Molecular-Mechanics Study of Oligomeric Models for Polyferrocenylsilanes Using the Esff Forcefield. Chem. Commun. 1996, 256. For another example of molecular modeling on hemes, see: Ranghino, G.; Fantucci, P. Molecular modeling of Heme Peptides-Molecular Dynamics Simulation of Microperoxidase. Israel Chem. 1994, 34, 239-244.
29. Rodighiero, P.; Guiotto, A.; Chilin, A.; Bordin, F.; Baccicheti, F.; Carlassare, F.; Vedaldi, D.; Caffieri, S.; Pozzan, A.; Dall'Acqua, F. D. Angular Furoquinolinones, Psoralen Analogs: Novel Antiproliferative Agents for Skin Diseases. Synthesis, Biological Activity, Mechanism of Action, and Computer-Aided Studies. J. Med. Chem. 1996, 39, 1293-1302. See also J. Mol. Graph. 1993, 13, 215.
30. Rodighiero, P.; Guiotto, A.; Chilin, A.; Bordin, F.; Baccicheti, F.; Carlassare, F.; Vedaldi, D.; Caffieri, S.; Pozzan, A.; Dall'Acqua, F. D. Angular Furoquinolinones, Psoralen Analogs: Novel Antiproliferative Agents for Skin Diseases. Synthesis, Biological Activity, Mechanism of Action, and Computer-Aided Studies. J. Med. Chem. 1996, 39, 1293-1302. See also J. Mol. Graph. 1993, 13, 215.
31. Wang, S.; Kazanietz, M. G.; Blumberg, P. M.; Marquez, V. E., Milne, G. W. A., Molecular modeling and Site-Directed Mutagenesis Studies of a Phorbol Ester-Binding Site in Protein Kinase C. J. Med. Chem. 1996, 39, 2541-2553.
32. Constantinindis, I.; Saterlee, J. D. UV-Visible and Carbon NMR Studies of Chloroquine Binding to Urohemin I Chloride and Uroporphyrin I in Aqueous Solutions. J. Am. Chem. Soc. 1988, 110, 4391-4395.
33. Moreau, S.; Perly, B.; Chachaty, C.; Deleuze, C. A Nuclear Magnetic Resonance Study of the Interactions of Antimalarial Drugs with Porphyrins. Biochim. Biophys. Acta 1985, 840, 107-116.
34. ligand
35. Yennawar, H. P.; Viswamitra, M. A. Steric and Rotational Constraints in the X-Ray Structure of the Antimalarial Drug Amodiaquine. Curr. Sci. 1991, 61, 39-43.
36. (a) Chou, A. C.; Fitch, C. D. Mechanism of Hemolysis Induced by Ferriprotoporpyrin IX. J. Clin. Invest. 1981, 672-677.
37. (b) Sugioka, Y.; Suzuki, M.; Sugioka, K.; Nakano, M. A Ferriprotoporphyrin IX-Chloroquine Complex Promotes Membrane Phospholipid Peroxidation. FEBS Lett. 1987, 223, 251-254.
38. Orjih, A. U.; Banyal, H. S.; Chevli, R.; Fitch, C. D. Hemin Lyses Malaria Parasites. Science 1981, 214, 667-669.
39. Slater, A. F. G.; Swiggard, W. J.; Orton, B. R.; Flitter, W. D.; Goldberg, D. E.; Cerami, A.; Henderson, G. B. An Iron-Carboxylate Bond Links the Heme Units of Malaria Pigment. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 325-329.
40. Slater, A. F. G. Malaria Pigment. Exp. Parasitol. 1992, 74, 362-365.
41. Warhurst, D. C. Antimalarial Interaction with Ferriprotoporphyrin IX Monomer and its Relationship to Activity of Blood Schizonticides. Ann. Trop. Med. Parasitol. 1987, 81, 65-67.
42. Ginsburg, H.; Krugliak, M. Effects of Quinoline Containing Antimalarials on the Erythrocyte Membrane and Their Significance to Drug Action on Plasmodium Falciparum. Biochem. Pharmacol. 1988, 37, 2013-2018.
43. Ginsburg, H.; Demel, R. A. Interactions of Hemin, Antimalarial Drugs and Hemin-Antimalarial Complexes with Phopolipid Monolayers. Chem. Phys. Lipid 1984, 35, 331-347.
44. 4 = 8.65 Å.
45. Yayon, A.; Cabantchik, Z. I.; Ginsburg, H. Identification of the Acidic Compartment of Plasmodium Falciparum-Infected Human Erythrocytes as the Target of the Antimalarial Drug Chloroquine. EMBO J. 1984, 11, 2695-2700.
46. Park, B. K.; Kitteringham, N. R. Effects of Fluorine Substitution on Drug Metabolism: Pharmacological and Toxicological Implications. Drug Metab. Rev. 1994, 26, 605-643.
47. For a detailed examination of the effect on antimalarial activity of replacing the N-diethylamino of amodiaquine with the N-tert-butyl group, see: Hawley, S. R.; Bray, P. G.; O'Neill, P. M.; Naisbitt, D. J.; Park, B. K.; Ward, S. A. Manipulation of the N-Alkyl Substituent in Amodiaquine to Overcone the Verapamil Sensitive Chloroquine Resistance Mechanism. Antimicrob. Agents Chemother. 1996, 40, 2345-2349.